Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HESLOP, Helen E")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 68

  • Page / 3
Export

Selection :

  • and

How I treat EBV lymphoproliferationHESLOP, Helen E.Blood. 2009, Vol 114, Num 19, pp 4002-4008, issn 0006-4971, 7 p.Article

Viral lymphomagenesisAHMED, Nabil; HESLOP, Helen E.Current opinion in hematology. 2006, Vol 13, Num 4, pp 254-259, issn 1065-6251, 6 p.Article

Cytotoxic T lymphocytes as immune-therapy in haematological practiceLEEN, Ann M; HESLOP, Helen E.British journal of haematology. 2008, Vol 143, Num 2, pp 169-179, issn 0007-1048, 11 p.Article

Gene-marking studies of hematopoietic cellsBOLLARD, Catherine M; HESLOP, Helen E; BRENNER, Malcolm K et al.International journal of hematology. 2001, Vol 73, Num 1, pp 14-22, issn 0925-5710Article

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative diseaseBOLLARD, Catherine M; SAVOLDO, Barbara; ROONEY, Cliona M et al.Acta haematologica. 2003, Vol 110, Num 2-3, pp 139-148, issn 0001-5792, 10 p.Article

Immunotherapy for post-transplant lymphoproliferative diseaseSTRAATHOF, Karin C. M; SAVOLDO, Barbara; HESLOP, Helen E et al.British journal of haematology. 2002, Vol 118, Num 3, pp 728-740, issn 0007-1048Article

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. CommentaryHESLOP, Helen E; BERGER, Carolina; FLOWERS, Mary E et al.Blood. 2006, Vol 107, Num 6, issn 0006-4971, 2211-2212,2294-2302 [11 p.]Article

Immunotherapy to reconstitute immunity to DNA virusesGAHN, Benedikt; HUNT, Garrett; ROONEY, Cliona M et al.Seminars in hematology. 2002, Vol 39, Num 1, pp 41-47, issn 0037-1963Article

Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's diseaseHULS, M. Helen; ROONEY, Cliona M; HESLOP, Helen E et al.Acta haematologica. 2003, Vol 110, Num 2-3, pp 149-153, issn 0001-5792, 5 p.Article

Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemiaGANGULY, Siddhartha; CARRUM, George; NIZZI, Frank et al.American journal of hematology. 2004, Vol 75, Num 1, pp 48-51, issn 0361-8609, 4 p.Article

Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous diseaseMARTINEZ, Caridad A; SHAH, Sweta; HAO LIU et al.Journal of allergy and clinical immunology. 2012, Vol 129, Num 1, pp 176-183, issn 0091-6749, 8 p.Article

Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of GlioblastomaGHAZI, Alexia; ASHOORI, Aidin; HEGDE, Meenakshi et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 2, pp 159-168, issn 1524-9557, 10 p.Article

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjectsMELENHORST, J. Joseph; LEEN, Ann M; BOLLARD, Catherine M et al.Blood. 2010, Vol 116, Num 22, pp 4700-4702, issn 0006-4971, 3 p.Article

Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytesPAKAKASAMA, Samart; EAMES, Gretchen M; MORRISS, Michael C et al.Transplantation. 2004, Vol 78, Num 5, pp 755-757, issn 0041-1337, 3 p.Article

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipientsSAVOLDO, Barbara; GOSS, John; ZHENSHENG LIU et al.Transplantation. 2001, Vol 72, Num 6, pp 1078-1086, issn 0041-1337Article

Interleukin 15 Provides Relief to CTLs from Regulatory T Cell―Mediated Inhibition: Implications for Adoptive T Cell―Based Therapies for LymphomaPERNA, Serena K; DE ANGELIS, Biagio; SAVOLDO, Barbara et al.Clinical cancer research (Print). 2013, Vol 19, Num 1, pp 106-117, issn 1078-0432, 12 p.Article

Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4CRUZ, Conrad R; GERDEMANN, Ulrike; ROONEY, Cliona M et al.Clinical cancer research (Print). 2011, Vol 17, Num 22, pp 7058-7066, issn 1078-0432, 9 p.Article

Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal CarcinomaLOUIS, Chrystal U; STRAATHOF, Karin; GEE, Adrian et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 9, pp 983-990, issn 1524-9557, 8 p.Article

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor modelDI STASI, Antonio; DE ANGELIS, Biagio; ROONEY, Cliona M et al.Blood. 2009, Vol 113, Num 25, pp 6392-6402, issn 0006-4971, 11 p.Article

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes. CommentaryDUDLEY, Mark E; QUINTARELLI, Concetta; DOTTI, Gianpietro et al.Blood. 2007, Vol 110, Num 8, issn 0006-4971, 2781-2782, 2793-2802 [12 p.]Article

Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infectionLEE, Timothy C; GOSS, John A; ROONEY, Cliona M et al.Clinical transplantation. 2006, Vol 20, Num 6, pp 689-694, issn 0902-0063, 6 p.Article

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4+ T cellsKUI SHIN VOO; TIHUI FU; HESLOP, Helen E et al.Cancer research (Baltimore). 2002, Vol 62, Num 24, pp 7195-7199, issn 0008-5472, 5 p.Article

Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic ActivityKENNEDY-NASSER, Alana A; KU, Stephanie; SAVOLDO, Barbara et al.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2215-2225, issn 1078-0432, 11 p.Article

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesCOHEN, Jeffrey I; JAFFE, Elaine S; BURBELO, Peter D et al.Blood. 2011, Vol 117, Num 22, pp 5835-5849, issn 0006-4971, 15 p.Article

High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsQUINTARELLI, Concetta; DOTTI, Gianpietro; HESLOP, Helen E et al.Blood. 2011, Vol 117, Num 12, pp 3353-3362, issn 0006-4971, 10 p.Article

  • Page / 3